Latest news with #Prenuvo
Yahoo
16-05-2025
- Health
- Yahoo
Company claims its AI body scan can detect more than 500 conditions, including early-stage cancers
For nearly an hour, Ernie Lopez sat still inside a narrow MRI tube. 'My biggest fear is if my nose itches,' said Ernie Lopez. Lopez underwent a full-body MRI scan through Prenuvo, a company that offers a variety of advanced MRI scans. Prenuvo claims its scans can detect over five hundred conditions, including early-stage cancers. Artificial Intelligence is used to analyze billions of data points, board-certified radiologists interpret the results, and patients receive detailed reports along with a consultation from a nurse practitioner. The information is accessible through the Prenuvo app. 'We're offering an extra layer of protection beyond standard medical care,' said Dr. Daniel Durand, Prenuvo's Chief Medical Officer. 'It's like a digital physical exam interpreted by a radiologist. It doesn't replace other tests — but it's powerful.' The scan comes with a price tag. Depending on the scan, Prenuvo charges between $999 and $4,499, and the scans are not covered by insurance. Prenuvo has gained popularity over the years through endorsements by celebrities like Kim Kardashian and Maria Menounos. But medical experts like Dr. Jennifer Haas, an Internist with Mass General Brigham, warn about false positives that could lead to invasive and unnecessary follow-up tests. 'Let's say the scan says, we think that you have cancer, but then you go on and get a biopsy on whatever that abnormality was, and it's not really cancer,' said Dr. Jennifer Haas. 'So you've then gone through the anxiety of having this evaluation to be told you don't have cancer. That's not a guarantee that six months from now you're not going to have cancer.' Dr. Haas says she wants more evidence before recommending it to her patients. For now, Dr. Haas encourages people with any type of symptoms to speak with their doctor first. Prenuvo is conducting a decade-long study in Watertown, Massachusetts, to assess the accuracy of its whole-body MRI screening. The study aims to enroll 100,000 participants and is a fully participant-funded study, with a scan fee of $2,200. Financial assistance is available for qualifying participants. For participants like Ernie Lopez, he hears the concerns and sees the price tag, but it's not holding him back. 'You have to take it with a grain of salt because I intend to go to my doctor after if there are any findings and hopefully conducting further checks,' said Ernie Lopez. 'If I can just get a marker so that in the future, if I need scans five, ten, fifteen years from now, we have a baseline.' Download the FREE Boston 25 News app for breaking news alerts. Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
Yahoo
15-05-2025
- Business
- Yahoo
Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer
Woodworth helped lead Peloton from pre-IPO to $4B+ in revenue, now she's bringing that experience to a pioneer in proactive health REDWOOD CITY, Calif., May 15, 2025--(BUSINESS WIRE)--Prenuvo, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO and beyond, Woodworth will lead Prenuvo's financial strategy, operations, and long-term planning as the company enters its next phase of growth. Woodworth is best known for her role as Chief Financial Officer at Peloton, where she helped scale the company from a late-stage startup into a publicly traded business with more than $4 billion in annual revenue at the time. She played a critical role in preparing the company for its IPO, navigating pandemic-era demand surges, and building operational infrastructure to support massive consumer adoption. Prior to Peloton, she spent over two decades as a Managing Director at J.P. Morgan and as an Executive Director at Morgan Stanley, advising Fortune 500 companies in the consumer and retail sectors on IPOs, M&A, and capital strategy. She most recently served as CFO at Alation, a data intelligence platform backed by top-tier investors. "What drew me to Prenuvo is the same thing that drew me to Peloton years ago, the opportunity to change lives at scale," said Jill Woodworth. "After experiencing a scan myself, I realized how powerful it is to truly see what's happening inside your body. The more I learned, the clearer it became that no one else in this space is approaching this like Prenuvo. I believe Prenuvo and proactive healthcare can become as ubiquitous and essential as fitness and wellness movements have become in the past decade. I'm excited to help build a future where taking control of your health is a natural, expected part of life for everyone." "Jill brings a rare combination of financial acumen and a deep understanding of consumer-driven health," said Andrew Lacy, Founder and CEO of Prenuvo Inc. "She's helped build one of the most recognized brands of the last decade, and her leadership will be essential as we scale globally and continue making proactive health more accessible." Prenuvo has quickly emerged as a category leader in proactive health and is now seeing record scan volumes month over month, driven by rising demand for early health insights across a broad range of consumer patient populations. Earlier this year, the company announced a historic milestone of 100,000 scans and net profitability. Since then, Prenuvo has surpassed 130,000 scans and introduced its Enhanced Scan, which combines whole-body imaging, advanced neuro screening, and blood diagnostics. In locations where it's available, the Enhanced Scan already accounts for a quarter of business, underscoring a growing demand for a single, trusted destination where patients can get a comprehensive view of their health without the complexity of piecing together multiple tests or providers. With 15 more locations set to launch - including the company's first sites in Europe and Australia - Prenuvo is scaling quickly to meet growing demand. Prenuvo integrates MRI technology, its proprietary scanning protocols, AI tools and in-house R&D, and clinical reporting into a single, unified experience, enabling tighter quality control and a more seamless path from scan to diagnosis. The Prenuvo Medical Group brings together 150+ healthcare practitioners, including the world's largest private radiology team dedicated entirely to proactive whole body MRI screening, with over 100 board-certified radiologists on staff. About Prenuvo Prenuvo makes MRI scanning for early detection of many types of cancer and many other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive full-body scans, Prenuvo's patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans. View source version on Contacts Media Contact: Christine Alabastromedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
15-05-2025
- Business
- Business Wire
Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Prenuvo, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO and beyond, Woodworth will lead Prenuvo's financial strategy, operations, and long-term planning as the company enters its next phase of growth. Woodworth is best known for her role as Chief Financial Officer at Peloton, where she helped scale the company from a late-stage startup into a publicly traded business with more than $4 billion in annual revenue at the time. She played a critical role in preparing the company for its IPO, navigating pandemic-era demand surges, and building operational infrastructure to support massive consumer adoption. Prior to Peloton, she spent over two decades as a Managing Director at J.P. Morgan and as an Executive Director at Morgan Stanley, advising Fortune 500 companies in the consumer and retail sectors on IPOs, M&A, and capital strategy. She most recently served as CFO at Alation, a data intelligence platform backed by top-tier investors. 'What drew me to Prenuvo is the same thing that drew me to Peloton years ago, the opportunity to change lives at scale,' said Jill Woodworth. 'After experiencing a scan myself, I realized how powerful it is to truly see what's happening inside your body. The more I learned, the clearer it became that no one else in this space is approaching this like Prenuvo. I believe Prenuvo and proactive healthcare can become as ubiquitous and essential as fitness and wellness movements have become in the past decade. I'm excited to help build a future where taking control of your health is a natural, expected part of life for everyone." 'Jill brings a rare combination of financial acumen and a deep understanding of consumer-driven health,' said Andrew Lacy, Founder and CEO of Prenuvo Inc. 'She's helped build one of the most recognized brands of the last decade, and her leadership will be essential as we scale globally and continue making proactive health more accessible.' Prenuvo has quickly emerged as a category leader in proactive health and is now seeing record scan volumes month over month, driven by rising demand for early health insights across a broad range of consumer patient populations. Earlier this year, the company announced a historic milestone of 100,000 scans and net profitability. Since then, Prenuvo has surpassed 130,000 scans and introduced its Enhanced Scan, which combines whole-body imaging, advanced neuro screening, and blood diagnostics. In locations where it's available, the Enhanced Scan already accounts for a quarter of business, underscoring a growing demand for a single, trusted destination where patients can get a comprehensive view of their health without the complexity of piecing together multiple tests or providers. With 15 more locations set to launch - including the company's first sites in Europe and Australia - Prenuvo is scaling quickly to meet growing demand. Prenuvo integrates MRI technology, its proprietary scanning protocols, AI tools and in-house R&D, and clinical reporting into a single, unified experience, enabling tighter quality control and a more seamless path from scan to diagnosis. The Prenuvo Medical Group brings together 150+ healthcare practitioners, including the world's largest private radiology team dedicated entirely to proactive whole body MRI screening, with over 100 board-certified radiologists on staff. About Prenuvo Prenuvo makes MRI scanning for early detection of many types of cancer and many other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive full-body scans, Prenuvo's patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans.
CBS News
14-05-2025
- Health
- CBS News
Viral full body scan offers North Texans preventative health insights
As more people embrace health and wellness trends, a new clinic in North Texas is offering a high-tech way to look beneath the surface. Prenuvo, a company operating in Irving, provides full-body MRI scans that claim to detect early signs of more than 500 medical conditions, including cancer, brain aneurysms, and other serious illnesses. Prenuvo "We like to call it an inside-outside physical," said Julia Glaser, a representative for Prenuvo. The scan takes less than an hour and gives patients a comprehensive view of their internal health, without invasive procedures. The company's rapid growth has been fueled by social media buzz and celebrity endorsements, including viral TikTok videos and support from Kim Kardashian. "When you're looking at what's happening on the inside, and how it's not manifesting on the outside, it's wild," Glaser said. Unlike traditional MRIs that focus on a specific area, Prenuvo scans the entire body in one session. That concept caught the attention of Shayla Dunlap, a local family nurse practitioner. "My patients were asking me about it," Dunlap said. Curious, she tried the scan herself. While she emphasized it shouldn't replace regular medical care or screenings, she believes it could be a powerful tool for early detection. "What I was looking for out of the scan was peace of mind. And it definitely brought me peace of mind," she said. In Dunlap's case, there were no major findings. But clinic staff said the scans have made a difference for others. "In one case, we had a man come in. We were joking, everything was fine, we got him on the machine, and our jaws just dropped," Glaser said. "This individual had cancer all throughout his body." After the scan, results are reviewed by a radiologist and delivered through an app. A nurse practitioner also walks patients through the findings. "When you're able to catch something before it escalates to multi-system effects, the treatment options and outcomes are just so much better," Glaser said. The full-body scan costs about $2,500. Prenuvo hopes that as technology advances and demand increases, the service will become more accessible and affordable for anyone seeking peace of mind through preventive care.
CNBC
05-05-2025
- Business
- CNBC
Function Health buys Ezra, launches full-body scan for a third of the price
Blood testing startup Function Health on Monday announced the acquisition of full-body MRI scanning company Ezra and launched a new, 22-minute scan for $499. Function offers a $499 annual subscription where members complete more than 160 blood tests and track their results over time. The company said adding Ezra's scanning technology to its platform will allow its users to screen for more conditions and access a more complete picture of their health. "It makes so much sense," Jonathan Swerdlin, the co-founder and CEO of Function, said in an interview. "What labs aren't covering, scans can see, and what scans couldn't touch on, labs cover." Function and Ezra declined to disclose the financial details of the acquisition. Before Monday's announcement, Ezra's cheapest offering was a 30-minute scan that cost participants $1,495. Ezra, founded in 2018, offers a range of full-body MRI scans that can help patients detect cancer and other conditions. The company partners with existing imaging facilities across more than 70 locations in the U.S., according to its website. Full-body MRI scans have surged in popularity in recent years after celebrities like Kim Kardashian began posting about them on social media. Medical experts have mixed feelings about the screenings, in part because they're expensive, can result in unnecessary care and can cause patients to worry. Ezra's primary competitor is Prenuvo, another full-body MRI scanning startup. In February, Prenuvo announced that it closed a $120 million funding round, and it also launched a new blood test to provide insights into patients' hormonal, cardiovascular, metabolic and immune health. Ezra has raised a total of $44 million from investors, while Function has raised a total of $53 million as of June 2024. Function is reportedly seeking more than $200 million in fresh capital at a valuation of around $2 billion, according to a February report from Bloomberg. Emi Gal, the founder and CEO of Ezra, said he has known Function's Swerdlin for years, and that the two began chatting last year about potentially collaborating through a commercial partnership. Over time, though, he said it became clear that an acquisition ultimately made more sense. "I'm pinching myself," Gal said in an interview. "This is just a phenomenal outcome." The company was able to shorten its new scan time to 22 minutes by leveraging artificial intelligence that was cleared by the U.S. Food and Drug Administration in January, Gal said. The AI, as well as Function's "financial prowess," helped reduce the price of the scan to $499, he added. The new 22-minute scan will be available to Function members starting on Monday. Function does not publicly disclose how many patients subscribe to its platform, but Swerdlin said it's in the "hundreds of thousands." Dr. Mark Hyman, co-founder and the chief medical officer of Function, said acquiring Ezra was a natural part of Function's evolution. "What used to be the domain of the wealthy is now accessible to everybody, including comprehensive imaging," Hyman said in an interview. "It truly makes a difference for people and saves lives."
